Polycystic ovary syndrome and cardiovascular risk profile

被引：0
作者：
Bohlen, Sophia-Marie [1 ]
Kiesel, Ludwig [2 ]
机构：
[1] A&P MVZ GmbH, Pruner Gang 7, D-24103 Kiel, Germany
[2] Univ Klinikum Munster, Klin Frauenheilkunde & Geburtshilfe, Munster, Germany
来源：
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2024年 / 22卷 / 03期
关键词：
DIAGNOSTIC-CRITERIA; INSULIN-RESISTANCE; METABOLIC SYNDROME; WOMEN; EPIDEMIOLOGY; HYPERTENSION; PREVALENCE; PREDICTORS; FEATURES;
D O I：
10.1007/s10304-024-00569-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：216 / 220
页数：5
相关论文
共 26 条
  • [1] Boumosleh JM, 2017, J ENDOCR SOC, V1, P1417, DOI 10.1210/js.2017-00323
  • [2] The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
    Bozdag, Gurkan
    Mumusoglu, Sezcan
    Zengin, Dila
    Karabulut, Erdem
    Yildiz, Bulent Okan
    [J]. HUMAN REPRODUCTION, 2016, 31 (12) : 2841 - 2855
  • [3] Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
    Cibula, D
    Cífková, R
    Fanta, M
    Poledne, R
    Zivny, J
    Skibová, J
    [J]. HUMAN REPRODUCTION, 2000, 15 (04) : 785 - 789
  • [4] Cree-Green M, 2017, J ENDOCR SOC, V1, P931, DOI 10.1210/js.2017-00192
  • [5] Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan, Nadine M. P.
    Louwers, Yvonne V.
    Koster, Maria P. H.
    Eijkemans, Marinus J. C.
    de Rijke, Yolanda B.
    Lentjes, Eef W. G.
    Fauser, Bart C. J. M.
    Laven, Joop S. E.
    [J]. FERTILITY AND STERILITY, 2014, 102 (05) : 1444 - 1451.e3
  • [6] Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
    Dumesic, Daniel A.
    Oberfield, Sharon E.
    Stener-Victorin, Elisabet
    Marshall, John C.
    Laven, Joop S.
    Legro, Richard S.
    [J]. ENDOCRINE REVIEWS, 2015, 36 (05) : 487 - 525
  • [7] Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
    Ehrmann, DA
    Liljenquist, DR
    Kasza, K
    Azziz, R
    Legro, RS
    Ghazzi, MN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) : 48 - 53
  • [8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
    Fauser, BCJM
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. HUMAN REPRODUCTION, 2004, 19 (01) : 41 - 47
  • [9] Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
    Glintborg, Dorte
    Rubin, Katrine Hass
    Nybo, Mads
    Abrahamsen, Bo
    Andersen, Marianne
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [10] Gomez JMD, SUBCLINICAL CARDIOVA, DOI [10.1016/j.fertnstert.2022.02.028, DOI 10.1016/J.FERTNSTERT.2022.02.028]
123